{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:20:28Z","timestamp":1793845228966,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T00:00:00Z","timestamp":1623715200000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jhep.2020.03.039","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T11:36:07Z","timestamp":1586345767000},"page":"202-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4063,"title":["A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement"],"prefix":"10.1016","volume":"73","author":[{"given":"Mohammed","family":"Eslam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv K.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin M.","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Zelber-Sagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Wai-Sun Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Shiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tiribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Yki-J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Gao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Cortez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia P.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bedossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wah-Kheong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahum","family":"Mendez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Castera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Ratziu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.03.039_bib1","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.03.039_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & hepatology Commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13679-018-0317-8","article-title":"Epidemiology of obesity in adults: latest trends","volume":"7","author":"Inoue","year":"2018","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.jhep.2020.03.039_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","article-title":"Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans","volume":"26","author":"Stefan","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2020.03.039_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/met.2018.0105","article-title":"Prevalence of optimal metabolic health in American adults: national health and nutrition examination survey 2009-2016","volume":"17","author":"Araujo","year":"2019","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jhep.2020.03.039_bib7","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2019.05.064","article-title":"Toward more accurate nomenclature for fatty liver diseases","volume":"157","author":"Eslam","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.03.039_bib8","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib9","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Cleeman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.03.039_bib10","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.03.039_bib11","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2020.03.039_bib12","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2020.03.039_bib13","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jhep.2020.03.039_bib14","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142018","volume":"41","author":"Association","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2020.03.039_bib15","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.29607","article-title":"Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science","volume":"67","author":"Siddiqui","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-Part 1: definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib19","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver Stiffness Measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.03.039_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Di Angelantonio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.03.039_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/oby.2010.174","article-title":"The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-Ray absorptiometry","volume":"19","author":"Shea","year":"2011","journal-title":"Obesity"},{"issue":"6","key":"10.1016\/j.jhep.2020.03.039_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu8060320","article-title":"Does metabolically healthy obesity exist?","volume":"8","author":"Munoz-Garach","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.jhep.2020.03.039_bib24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","article-title":"Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study","volume":"6","author":"Eckel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jhep.2020.03.039_bib25","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically healthy obese and incident cardiovascular disease events among 3.5 Million men and women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jhep.2020.03.039_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/eurheartj\/ehx448","article-title":"Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis","volume":"39","author":"Lassale","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhep.2020.03.039_bib27","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15015","article-title":"The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity","volume":"48","author":"Ampuero","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.03.039_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.03.039_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/17474124.2019.1649981","article-title":"Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations","volume":"13","author":"Arrese","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2020.03.039_bib30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/apm.12742","article-title":"Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study","volume":"125","author":"Rastogi","year":"2017","journal-title":"APMIS"},{"key":"10.1016\/j.jhep.2020.03.039_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.metabol.2019.05.002","article-title":"Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study","volume":"97","author":"Cho","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2020.03.039_bib33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.28985","article-title":"Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease","volume":"65","author":"Bril","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib34","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.29094","article-title":"Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit","volume":"65","author":"Rotman","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib35","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A\u00a0systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with Advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.03.039_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.03.039_bib39","doi-asserted-by":"crossref","first-page":"e1912565","DOI":"10.1001\/jamanetworkopen.2019.12565","article-title":"Association of histologic disease activity with progression of nonalcoholic fatty liver disease","volume":"2","author":"Kleiner","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jhep.2020.03.039_bib40","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30418","article-title":"Improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic steatohepatitis: results from the nonalcoholic steatohepatitis clinical research network treatment trials","volume":"70","author":"Brunt","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib41","unstructured":"Ratziu V, Harrison SA, Francque S, Bedossa P, Anstee QM, Ben S, et\u00a0al. ALT as a non-invasive biomarker of histological response to pharmacotherapy in NASH patients: insights from the elafibranor GOLDEN505 trial. 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016; 2016: Newcastle University."},{"key":"10.1016\/j.jhep.2020.03.039_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.28276","article-title":"Time to abandon NASH?","volume":"63","author":"Dufour","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2017.11.018","article-title":"Is cryptogenic cirrhosis different from NASH cirrhosis?","volume":"68","author":"Thuluvath","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2017.12.006","article-title":"Cryptogenic vs. NASH-cirrhosis: the rose exists well before its name\u2026","volume":"68","author":"Caldwell","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib45","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2018.08.013","article-title":"The conundrum of cryptogenic cirrhosis: adverse outcomes without treatment options","volume":"69","author":"Younossi","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.03.039_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2017.11.006","article-title":"The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease","volume":"68","author":"Boyle","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.MP.0000042420.21088.C7","article-title":"Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease","volume":"16","author":"Brunt","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhep.2020.03.039_bib49","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s10620-004-9600-5","article-title":"Histologic features of steatohepatitis in patients with a clinical diagnosis of autoimmune cholestasis","volume":"49","author":"Sanchez-Munoz","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2020.03.039_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1478-3231.1999.tb00053.x","article-title":"Nonalcoholic steatohepatitis: a toxic liver disease in industrial workers","volume":"19","author":"Cotrim","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2020.03.039_bib51","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"De Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2020.03.039_bib52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hep.30857","article-title":"Non-Alcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B","volume":"71","author":"Choi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cld.2013.09.006","article-title":"The impact of obesity and metabolic syndrome on alcoholic liver disease","volume":"18","author":"Chiang","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2020.03.039_bib54","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.29055","article-title":"Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review","volume":"65","author":"Ajmera","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.03.039_bib55","doi-asserted-by":"crossref","first-page":"488","DOI":"10.15288\/jsad.2017.78.488","article-title":"Editor's corner: binge drinking and the evolving language of alcohol research","volume":"78","author":"Ceballos","year":"2017","journal-title":"J\u00a0Stud Alcohol Drugs"},{"key":"10.1016\/j.jhep.2020.03.039_bib56","doi-asserted-by":"crossref","DOI":"10.2174\/1381612826666200122151251","article-title":"Genetics and epigenetics in the clinic: precision medicine in the management of fatty liver disease","author":"Cespiati","year":"2020","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jhep.2020.03.039_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib59","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cgh.2017.04.045","article-title":"Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity","volume":"15","author":"Fracanzani","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.03.039_bib60","series-title":"Designing Clinical Research","author":"Hulley","year":"2007"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820302014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820302014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T15:19:14Z","timestamp":1716650354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820302014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0168827820302014"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}